Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Other Non-Current Liabilities (2021 - 2025)

Historic Other Non-Current Liabilities for Abeona Therapeutics (ABEO) over the last 10 years, with Q3 2025 value amounting to $22.6 million.

  • Abeona Therapeutics' Other Non-Current Liabilities rose 195145.45% to $22.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.6 million, marking a year-over-year increase of 195145.45%. This contributed to the annual value of $32.0 million for FY2024, which is 211.15% up from last year.
  • Per Abeona Therapeutics' latest filing, its Other Non-Current Liabilities stood at $22.6 million for Q3 2025, which was up 195145.45% from $30.2 million recorded in Q2 2025.
  • In the past 5 years, Abeona Therapeutics' Other Non-Current Liabilities registered a high of $48.7 million during Q1 2024, and its lowest value of $200000.0 during Q1 2022.
  • Moreover, its 5-year median value for Other Non-Current Liabilities was $23.3 million (2024), whereas its average is $19.7 million.
  • Per our database at Business Quant, Abeona Therapeutics' Other Non-Current Liabilities surged by 1346100.0% in 2023 and then plummeted by 9594.43% in 2024.
  • Over the past 5 years, Abeona Therapeutics' Other Non-Current Liabilities (Quarter) stood at $9.0 million in 2021, then soared by 118.24% to $19.7 million in 2022, then skyrocketed by 59.5% to $31.4 million in 2023, then increased by 2.11% to $32.0 million in 2024, then fell by 29.51% to $22.6 million in 2025.
  • Its Other Non-Current Liabilities was $22.6 million in Q3 2025, compared to $30.2 million in Q2 2025 and $24.8 million in Q1 2025.